Effect of hyperbaric oxygen and ulinastatin on plasma endotoxin , soluble CD 14 , endotoxin-neutralizing capacity and cytokines in acute necrotizing pancreatitis

Methods: We randomly allocated 90 Sprague–Dawley rats into 6 groups: group 1 (ordinary control), group 2 (sham operation), group 3 (ANP), group 4 (ANP with HBO), group 5 (ANP with ulinastatin) and group 6 (ANP with HBO and ulinastatin). We induced ANP by retrograde injection of 3.5% sodium taurocholate (2.5 mL/kg) via the pancreatic duct. Five minutes after induction, animals in groups 5 and 6 were infused with ulinastatin (20 000 U/kg) via the portal vein. Thirty minutes after induction, animals in groups 4 and 6 received HBO therapy. We collected samples 3, 6 and 10 hours after induction of ANP.

[1]  I. Sheen,et al.  Endotoxemia contributes to the immune paralysis in patients with cirrhosis. , 2007, Journal of hepatology.

[2]  T. Matsui,et al.  Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial , 2007, Journal of Gastroenterology.

[3]  C. Christophi,et al.  POTENTIAL EFFECTS OF HYPERBARIC OXYGEN THERAPY IN ACUTE PANCREATITIS , 2006, ANZ journal of surgery.

[4]  N. Ishimura,et al.  Ulinastatin shows preventive effect on post‐endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study , 2006, Journal of gastroenterology and hepatology.

[5]  Xingpeng Wang,et al.  Roles of Endotoxin-related Signaling Molecules in the Progression of Acute Necrotizing Pancreatitis in Mice , 2005, Pancreas.

[6]  A. Işık,et al.  Hyperbaric oxygen-induced changes in bacterial translocation and acinar ultrastructure in rat acute necrotizing pancreatitis , 2005, Journal of Gastroenterology.

[7]  T. Yoshikawa,et al.  Urinary Trypsin Inhibitor Protects against Systemic Inflammation Induced by Lipopolysaccharide , 2005, Molecular Pharmacology.

[8]  M. McMahon,et al.  Soluble CD14 receptor expression and monocyte heterogeneity but not the C-260T CD14 genotype are associated with severe acute pancreatitis , 2004, Critical care medicine.

[9]  G. Schmid-Schönbein,et al.  Pancreatic enzymes sustain systemic inflammation after an initial endotoxin challenge. , 2003, Surgery.

[10]  S. Opal,et al.  Endotoxin as a drug target , 2003, Critical care medicine.

[11]  N. Ganguly,et al.  Significance of Serum Endotoxin and Antiendotoxin Antibody Levels in Predicting the Severity of Acute Pancreatitis , 2002, Surgery Today.

[12]  H. Tsujimoto,et al.  Mechanism of the inhibitory effect of protease inhibitor on tumor necrosis factor alpha production of monocytes. , 2001, Shock.

[13]  K. Moore,et al.  Divergent Response to LPS and Bacteria in CD14-Deficient Murine Macrophages1 , 2000, The Journal of Immunology.

[14]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[15]  R. Ulevitch,et al.  Anti-CD14 mAb treatment provides therapeutic benefit after in vivo exposure to endotoxin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Ueng,et al.  Hyperbaric oxygen therapy attenuates pancreatic microcirculatory derangement and lung edema in an acute experimental pancreatitis model in rats. , 1998, Pancreas.

[17]  M. Aibiki,et al.  Ulinastatin, a human trypsin inhibitor, inhibits endotoxin-induced thromboxane B2 production in human monocytes. , 1997, Critical care medicine.

[18]  W. White,et al.  Relationship of preoperative antiendotoxin core antibodies and adverse outcomes following cardiac surgery. , 1997, JAMA.

[19]  Y. Skornick,et al.  Effects of delayed administration of octreotide in acute experimental pancreatitis. , 1996, The Journal of surgical research.

[20]  R. Landmann,et al.  Function of soluble CD14 in serum from patients with septic shock. , 1996, The Journal of infectious diseases.

[21]  L. Kinzl,et al.  Endotoxemia and specific antibody behavior against different endotoxins following multiple injuries. , 1995, The Journal of trauma.

[22]  G. Ramsay,et al.  A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides , 1993, Infection and immunity.

[23]  M. Glauser,et al.  Septic shock: pathogenesis , 1991, The Lancet.

[24]  H. Beger,et al.  Correlation between endotoxin‐neutralizing capacity of human plasma as tested by the limulus‐amebocyte‐lysate‐test and plasma protein levels , 1990, FEBS letters.

[25]  M. Büchler,et al.  Bacterial contamination of pancreatic necrosis. A prospective clinical study. , 1986, Gastroenterology.

[26]  J. Cohen,et al.  Observations on the measurement and evaluation of endotoxemia by a quantitative limulus lysate microassay. , 1984, The Journal of infectious diseases.

[27]  G. Takahashi,et al.  Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis , 2005, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[28]  A. Korkmaz,et al.  The effect of hyperbaric oxygen treatment on oxidative stress in experimental acute necrotizing pancreatitis. , 2003, Physiological research.